Is there a role for Ethics Committees in Pre-approval Access?
Stuart Bell, Vice President, Consulting, Inceptua Medicines Access In discussions with our clients over recent months the topic of ethics…
Read More Insights
Stuart Bell, Vice President, Consulting, Inceptua Medicines Access In discussions with our clients over recent months the topic of ethics committee involvement in pre-approval access programs (expanded access, compassionate use,…
Typically, there are three ways in which patients can get access to a medicine; through a clinical trial, when it is commercially available, or via a pre-approval / unlicensed medicines…
News and Press Releases
Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe December 28 2020, Elevar Therapeutics, Inc, a fully integrated biopharmaceutical company built…
LUXEMBOURG, Dec. 3, 2020 Inceptua announces that the company has entered into a partnership with Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company focused on discovering, developing and delivering treatments…
LUXEMBOURG – 25 September, 2020 – Inceptua Group – pharmaceutical company and service partner announces that the European Commission (EC) has approved the transfer of the marketing authorisation for Jetrea®…
